These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3938294)

  • 1. Intercellular distribution of HLA-DR and T6 antigens in the epidermis of various dermatoses.
    Willemze R; Dijkstra A; Nugteren WM
    Br J Dermatol; 1985 Dec; 113(6):802-4. PubMed ID: 3938294
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
    Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
    Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR expression on keratinocytes is a common feature of diseased skin.
    Auböck J; Romani N; Grubauer G; Fritsch P
    Br J Dermatol; 1986 Apr; 114(4):465-72. PubMed ID: 2421756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous detection of T6 and HLA-DR antigens distinguishes three cell subpopulations in dispersed normal human epidermal cells.
    Dezutter-Dambuyant C; Faure M; Schmitt D; Laquoi C; Thivolet J
    Immunol Lett; 1984; 7(4):203-7. PubMed ID: 6423529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of HLA-DR expression by human epidermal cells after growth in culture.
    Hefton JM; Amberson JB; Biozes DG; Weksler ME
    J Invest Dermatol; 1984 Jul; 83(1):48-50. PubMed ID: 6376639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of cutaneous Langerhans' cells of sarcoidosis patients.
    Berman B; Fox JL; Teirstein AS
    Ann N Y Acad Sci; 1986; 465():250-9. PubMed ID: 3089102
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA-DR antigen expression on the keratinocyte surface in dermatoses characterized by lymphocytic exocytosis (e.g. pityriasis rosea).
    Aiba S; Tagami H
    Br J Dermatol; 1984 Sep; 111(3):285-94. PubMed ID: 6206885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocyte class II histocompatibility antigen expression.
    Nickoloff BJ; Basham TY; Merigan TC; Morhenn VB
    Br J Dermatol; 1985 Mar; 112(3):373-4. PubMed ID: 3856455
    [No Abstract]   [Full Text] [Related]  

  • 9. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures.
    Demidem A; Faure M; Dezutter-Dambuyant C; Thivolet J
    Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances of ultrastructural immunocytochemistry of epidermal Langerhans cells.
    Schmitt D; Dezutter-Dambuyant C; Faure M; Thivolet J
    Br J Dermatol; 1985 Jul; 113 Suppl 28():2-9. PubMed ID: 3925979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of T6 antigen on the epidermal keratinocytes in various dermatoses.
    Br J Dermatol; 1986 Oct; 115(4):511-4. PubMed ID: 2430608
    [No Abstract]   [Full Text] [Related]  

  • 12. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
    van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
    J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell membrane glycoproteins and Langerhans cells.
    Murphy GF
    Hum Pathol; 1985 Feb; 16(2):103-12. PubMed ID: 3882547
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expression of class II HLA antigens (HLA-DR, DQW1, DQW3) in normal skin and cutaneous pathology].
    Gomes M; Schmitt D; Dezutter-Dambuyant C; Capra JD; Thivolet J
    Pathol Biol (Paris); 1986 Mar; 34(3):157-64. PubMed ID: 3517784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HLA-DR (Ia like) antigen on epidermal keratinocytes in human dermatoses.
    Lampert IA
    Clin Exp Immunol; 1984 Jul; 57(1):93-100. PubMed ID: 6204802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-2-microglobulin and HLA-DR(Ia)-antigens in normal and pathological skin.
    Tjernlund U
    Acta Derm Venereol Suppl (Stockh); 1981; 94():1-40. PubMed ID: 6169248
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease.
    Volc-Platzer B; Majdic O; Knapp W; Wolff K; Hinterberger W; Lechner K; Stingl G
    J Exp Med; 1984 Jun; 159(6):1784-9. PubMed ID: 6202820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface expression of invariant gamma-chain of class II histocompatibility antigens in human skin.
    Claesson-Welsh L; Scheynius A; Tjernlund U; Peterson PA
    J Immunol; 1986 Jan; 136(2):484-90. PubMed ID: 2416807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens).
    Hanau D; Fabre M; Schmitt DA; Garaud JC; Pauly G; Tongio MM; Mayer S; Cazenave JP
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2901-5. PubMed ID: 3106979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods in laboratory investigation. Immunoelectron microscopic methods for demonstration of antigens on normal human melanocytes and other epidermal cells.
    van Duinen SG; Mauw BJ; de Graaff-Reitsma CB; Ruiter DJ
    Lab Invest; 1984 Jun; 50(6):733-41. PubMed ID: 6427521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.